Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Prevention02:59

Cancer Prevention

6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging molecular targets in gynaecologic cancers: clinical implications for personalized therapy.

Molecular biology reports·2026
Same author

Adherent-Invasive <i>Escherichia coli</i> (AIEC) in Crohn's Disease: A Bibliometric Analysis of 25 Years of Research (1999-2025).

Microorganisms·2026
Same author

Nano-plastic contamination in soil: impacts on rhizosphere volatile organic compound (VOC) signaling and rice disease susceptibility-a comprehensive review.

International journal of phytoremediation·2026
Same author

Chlorella vulgaris as a functional food and nutraceutical: bioactive composition, health-promoting mechanisms, applications, and current challenges.

Food & function·2026
Same author

Antibacterial and antibiofilm evaluation of biogenic ternary CuO-AgO-MgO nanocomposite against clinical isolates of carbapenem-resistant <i>Klebsiella pneumoniae</i>.

Artificial cells, nanomedicine, and biotechnology·2026
Same author

Green-synthesized ZnO-MnO nanocomposite as a potent antimicrobial and antibiofilm agent: protein leakage mechanism and synergistic interaction with cefotaxime.

Frontiers in microbiology·2026

Related Experiment Video

Updated: Sep 15, 2025

Isolation and Purification of Fungal &#946;-Glucan as an Immunotherapy Strategy for Glioblastoma
10:02

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

2.1K

Mushroom Bioactive Molecules as Anticancerous Agents: An Overview.

Ali Ikram1, Nasir A Ibrahim2, Muhammad Tayyab Arshad1,3

  • 1University Institute of Food Science and Technology The University of Lahore Lahore Pakistan.

Food Science & Nutrition
|July 15, 2025
PubMed
Summary

Mushrooms contain bioactive compounds that show promise in fighting cancer by inhibiting tumor growth and proliferation. These natural compounds offer a potential alternative or supplement to traditional chemotherapy, with fewer side effects.

Keywords:
cancerleukemiamushroomtumor

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.5K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.7K

Related Experiment Videos

Last Updated: Sep 15, 2025

Isolation and Purification of Fungal &#946;-Glucan as an Immunotherapy Strategy for Glioblastoma
10:02

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

2.1K
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.5K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.7K

Area of Science:

  • Mycology
  • Pharmacology
  • Oncology

Background:

  • Mushrooms are integral to Traditional Chinese Medicine (TCM), valued for promoting health.
  • Cancer remains a leading cause of death globally, with chemotherapy causing immunosuppression and increasing mortality risk.
  • Bioactive macromolecules from natural sources offer a promising avenue for cancer treatment.

Purpose of the Study:

  • To review the pharmacological activity of mushroom-derived compounds against cancer.
  • To explore the potential of mushrooms as a source of antitumor agents.
  • To elucidate the mechanisms of action for mushroom-based anticancer compounds.

Main Methods:

  • Literature review of studies on mushroom compounds and their anticancer effects.
  • Identification of key bioactive macromolecules in various mushroom species.
  • Analysis of documented mechanisms of action, including effects on cell proliferation and angiogenesis.

Main Results:

  • Mushrooms contain numerous bioactive macromolecules like beta-glucans and polysaccharides with demonstrated anticancer properties.
  • Specific mushroom genera, including *Ganoderma* and *Cordyceps*, show significant antitumor potential.
  • Mushroom compounds inhibit cancer growth by inducing reactive oxygen species, inhibiting kinases, and preventing angiogenesis.

Conclusions:

  • Mushrooms represent a valuable natural resource for developing novel anticancer therapies.
  • Mushroom-derived compounds offer a promising strategy to combat cancer with potentially fewer side effects than conventional treatments.
  • Further research into mushroom pharmacology can lead to new antitumor agents and treatment modalities.